跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hypertan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Hypertan
Approved
STANDARD
Hypertan
JM Tolmann Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
65bb27d4263cb41d
Company
JM Tolmann Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
65bb27d4263cb41d
Drug Approval Philippines Name
Hypertan
Product Name
Hypertan
Registration Number
DRP-1100
Brand Name
Hypertan
Generic Name
Losartan Potassium
Dosage Form
Film Coated Tablet
Dosage Strength
100 mg
Manufacturer
JM Tolmann Laboratories, Inc.
Trader
Interhealthcare Pharmaceuticals, Inc.
Distributor
TGP Pharma, Inc.
Issuance Date
25 July 2024
Expiry Date
17 December 2029
Pharmacologic Category
Angiotensin-2-Receptor Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
65bb27d4263cb41d
Type
Standard
Back to Philippines FDA Approvals